ADIAL PHARMACEUTICALS, INC.
POWER OF ATTORNEY
Reproduction of the Power of Attorney included in the 2025 Form 10-K signature pages
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and
appoints Cary Claiborne and Vinay Shah, and each of them, his true and lawful attorneys-in-fact and agents, with full
power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign any and
all amendments to this report, and to file the same, with all exhibits thereto, and other documents in connection therewith,
with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full
power and authority to do and perform each and every act and thing requisite and necessary to be done in connection
therewith, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that
said attorneys-in-fact and agents, or either of them or their or his substitutes or substitute, may lawfully do or cause to be
done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1934, this Annual Report on Form 10-K has been signed by the
following persons on behalf of the registrant and in the capacities and on the dates indicated.
/s/ Cary Claiborne
Cary Claiborne
Chief Executive Officer and President
(Principal Executive Officer)
March 5, 2026
/s/ Vinay Shah
Vinay Shah
Chief Financial Officer
(Principal Financial and Accounting Officer)
March 5, 2026
/s/ Kevin Schuyler
Kevin Schuyler, CFA
Chairman of the Board of Directors
March 5, 2026
/s/ J. Kermit Anderson
J. Kermit Anderson
Member of the Board of Directors
March 5, 2026
/s/ Robertson H. Gilliland
Robertson H. Gilliland
Member of the Board of Directors
March 5, 2026
/s/ Tony Goodman
Tony Goodman
Member of the Board of Directors
March 5, 2026
Source: U.S. Securities and Exchange Commission, Adial Pharmaceuticals, Inc. Form 10-K for the fiscal year ended December 31, 2025, filed March
5, 2026. This PDF is a readable reproduction, not the original SEC-filed document.